The New England
Journal of Medicine (May 11, 2000. v342: 1392-1398)
Beneficial effects of high dietary fiber intake in
patients with type 2
diabetes mellitus.
"A high intake of dietary fiber,
particularly of the soluble type,
above the level recommended by the ADA, improves glycemic control,
decreases
hyperinsulinemia, and lowers plasma lipid concentrations in patients
with type
2 diabetes"
Clin
Excell Nurse Pract.(September 2000; 4 (5): 272-6)
Dietary fiber and type 2 diabetes.
"Water-soluble fiber appears to have a
greater potential to reduce
postprandial blood glucose, insulin, and serum lipid levels than
insoluble
fiber. Viscosity of the dietary fiber is important; the greater the
viscosity,
the greater the effect. "
Med
Hypotheses. (June 2002; (6): 487-90)
Glucomannan minimizes the postprandial insulin
surge: a potential adjuvant
for hepatothermic therapy.
"Glucomannan (GM) is differentiated from other soluble fibers by the
extraordinarily high viscosity of GM solutions. Administration of 4-5g
of GM
with meals, blended into fluid or mixed with food, can slow
carbohydrate
absorption and dampen the postprandial insulin response by up to 50%. "
Diabetes
Care (1999 Jun v22, i6; 913-919)
Konjac-mannan (glucomannan) improves glycemia and
other associated risk
factors for coronary heart disease in type 2 diabetes. A randomized
controlled
metabolic trial.
"KJM fiber added to conventional treatment may ameliorate glycemic
control, blood lipid profile, and SBP in high-risk diabetic
individuals,
possibly improving the effectiveness of conventional treatment in type
2
diabetes"
PDF Format
Diabetes
Care (2000; 23: 9 - 14)
Beneficial effects of viscous dietary fiber from
Konjac-mannan in subjects
with the insulin resistance syndrome: results of a controlled metabolic
trial.
"A diet rich in high-viscosity KJM improves glycemic control and lipid
profile, suggesting a therapeutic potential in the treatment of the
insulin
resistance syndrome."
PDF Format
Journal of the American
College of Nutrition (2003, February, 22(1): 36-42)
Konjac supplement alleviated hypercholesterolemia
and hyperglycemia in type
2 diabetic subjects--a randomized double-blind trial.
"The KGM supplement improved blood lipid
levels by enhancing fecal
excretion of neutral sterol and bile acid and alleviated the elevated
glucose
levels in diabetic subjects. KGM could be an adjunct for the treatment
of
hyperlipidemic diabetic subjects."